Comparison of outcomes for patients with acute myeloid leukemia undergoing haploidentical stem cell transplantation in first and second complete remission-Reference-Cited by-同舟云学术

Comparison of outcomes for patients with acute myeloid leukemia undergoing haploidentical stem cell transplantation in first and second complete remission

Published:2023-06-21 Issue:8 Volume:102 Page:2241-2250
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Yu Wen-Jing,Sun Yu-qian,Xu Lan-Ping,Zhang Xiao-Hui,Liu Kai-Yan,Huang Xiao-Jun,Wang Yu^ORCID

Funder

National Key Research and Development Program of China

National Natural Science Foundation of China

the Science and Technology Project of Guangdong Province of China

the project of health collaborative innovation of Guangzhou city

Beijing Municipal Science & Technology Commission

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00277-023-05324-0.pdf

Reference32 articles.

1. Xu L, Chen H, Chen J, Han M et al (2018) The consensus on indications, conditioning regimen, and donor selection of allogeneic hematopoietic cell transplantation for hematological diseases in China-recommendations from the Chinese Society of Hematology. J Hematol Oncol 11:33. https://doi.org/10.1186/s13045-018-0564-x

2. Dohner H, Estey EH, Amadori S et al (2010) Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood 115:453–474. https://doi.org/10.1182/blood-2009-07-235358

3. Koreth J, Schlenk R, Kopecky KJ et al (2009) Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials. JAMA 301:2349–2361. https://doi.org/10.1001/jama.2009.813

4. Kuwatsuka Y, Miyamura K, Suzuki R et al (2009) Hematopoietic stem cell transplantation for core binding factor acute myeloid leukemia: t(8;21) and inv(16) represent different clinical outcomes. Blood 113:2096–2103. https://doi.org/10.1182/blood-2008-03-145862

5. Wang Y, Liu DH, Liu KY et al (2013) Impact of pretransplantation risk factors on post transplantation outcome of patients with acute myeloid leukemia in remission after haploidentical hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 19:283–290. https://doi.org/10.1016/j.bbmt.2012.10.002

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of measurable residual disease in combination with CD19 on postremission therapy choices for adult t(8;21) acute myeloid leukemia in first complete remission;Cancer Medicine;2024-02

2. Early Allogeneic Transplantation Favorably Influences the Outcome of Pediatric Acute Myeloid Leukemia—A Retrospective Study in a Single Center Over 2 Decades;Transplantation Proceedings;2024-01